Stryker announces intention to nominate Manny Maceda to board of directors
Stryker (NYSE:SYK) has nominated Emmanuel "Manny" Maceda to its board of directors, with the election scheduled for the Annual Meeting of Shareholders on May 8, 2025. Maceda brings over 30 years of experience in leading organizations and advising executives on corporate transformations.
Maceda currently serves as Chairman of Bain & Company, following his role as Worldwide Managing Partner and CEO from 2018 to 2024. During his leadership, he drove Bain's global transformation across 50+ offices, strengthening digital capabilities and expanding sustainability focus. Since joining Bain in 1989, he has held various senior leadership positions and advised CEOs on strategy, growth, and organizational effectiveness.
Stryker (NYSE:SYK) ha nominato Emmanuel "Manny" Maceda nel suo consiglio di amministrazione, con l'elezione prevista per l'Assemblea Annuale degli Azionisti dell'8 maggio 2025. Maceda porta con sé oltre 30 anni di esperienza nella guida di organizzazioni e nella consulenza a dirigenti su trasformazioni aziendali.
Attualmente, Maceda ricopre il ruolo di Presidente di Bain & Company, dopo aver svolto il ruolo di Managing Partner Globale e CEO dal 2018 al 2024. Durante la sua leadership, ha guidato la trasformazione globale di Bain in oltre 50 uffici, rafforzando le capacità digitali e ampliando l'attenzione alla sostenibilità. Dall'ingresso in Bain nel 1989, ha ricoperto diverse posizioni di leadership senior e ha consigliato i CEO su strategia, crescita ed efficacia organizzativa.
Stryker (NYSE:SYK) ha nominado a Emmanuel "Manny" Maceda para su junta directiva, con la elección programada para la Asamblea Anual de Accionistas el 8 de mayo de 2025. Maceda aporta más de 30 años de experiencia en liderar organizaciones y asesorar a ejecutivos sobre transformaciones corporativas.
Actualmente, Maceda se desempeña como Presidente de Bain & Company, tras su rol como Socio Global y CEO de 2018 a 2024. Durante su liderazgo, impulsó la transformación global de Bain en más de 50 oficinas, fortaleciendo las capacidades digitales y ampliando el enfoque en sostenibilidad. Desde que se unió a Bain en 1989, ha ocupado diversas posiciones de liderazgo senior y ha asesorado a CEOs sobre estrategia, crecimiento y efectividad organizacional.
Stryker (NYSE:SYK)는 Emmanuel "Manny" Maceda를 이사회에 지명했으며, 선거는 2025년 5월 8일 주주 총회에서 예정되어 있습니다. Maceda는 조직을 이끌고 기업 변혁에 대해 경영진에게 조언하는 데 30년 이상의 경험을 가지고 있습니다.
현재 Maceda는 Bain & Company의 회장으로 활동하고 있으며, 2018년부터 2024년까지 전 세계 관리 파트너 및 CEO로 재직했습니다. 그의 리더십 아래, 그는 50개 이상의 사무소에서 Bain의 글로벌 변혁을 이끌며 디지털 역량을 강화하고 지속 가능성에 대한 초점을 확대했습니다. 1989년 Bain에 합류한 이후, 그는 다양한 고위 리더십 직책을 맡아 왔으며, CEO들에게 전략, 성장 및 조직의 효과성에 대해 조언해 왔습니다.
Stryker (NYSE:SYK) a nommé Emmanuel "Manny" Maceda au conseil d'administration, avec une élection prévue lors de l'Assemblée Générale des Actionnaires le 8 mai 2025. Maceda apporte plus de 30 ans d'expérience dans la direction d'organisations et le conseil aux dirigeants sur les transformations d'entreprise.
Maceda occupe actuellement le poste de Président de Bain & Company, après avoir été associé directeur mondial et PDG de 2018 à 2024. Sous sa direction, il a conduit la transformation mondiale de Bain dans plus de 50 bureaux, renforçant les capacités numériques et élargissant l'accent sur la durabilité. Depuis son arrivée chez Bain en 1989, il a occupé divers postes de direction et a conseillé des PDG sur la stratégie, la croissance et l'efficacité organisationnelle.
Stryker (NYSE:SYK) hat Emmanuel "Manny" Maceda in seinen Vorstand nominiert, die Wahl ist für die Hauptversammlung der Aktionäre am 8. Mai 2025 angesetzt. Maceda bringt über 30 Jahre Erfahrung in der Leitung von Organisationen und der Beratung von Führungskräften zu Unternehmensveränderungen mit.
Derzeit ist Maceda Vorsitzender von Bain & Company, nachdem er von 2018 bis 2024 als weltweiter Geschäftsführer und CEO tätig war. Während seiner Führung hat er die globale Transformation von Bain in über 50 Büros vorangetrieben, die digitalen Fähigkeiten gestärkt und den Fokus auf Nachhaltigkeit erweitert. Seit seinem Eintritt bei Bain im Jahr 1989 hat er verschiedene leitende Positionen innegehabt und CEOs in Bezug auf Strategie, Wachstum und organisatorische Effektivität beraten.
- Addition of experienced leader with extensive strategic transformation expertise
- Potential enhancement of board capabilities in digital transformation and sustainability
- Brings valuable global leadership experience from managing 50+ offices worldwide
- None.
Portage, Michigan, March 26, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its board of directors has nominated Emmanuel “Manny” Maceda for election to the company’s board at the 2025 Annual Meeting of Shareholders, scheduled for May 8, 2025.
Manny brings more than 30 years of experience leading high-performing organizations and advising senior executives on large-scale corporate transformations. He currently serves as Chairman of Bain & Company, following his tenure as Worldwide Managing Partner and CEO from 2018 to 2024. In that role, he led Bain’s global strategy and operations across more than 50 offices, driving the firm’s transformation to strengthen digital capabilities, expand its focus on sustainability, and preserve its award-winning culture.
Since joining Bain in 1989, Maceda has held multiple senior leadership roles and advised CEOs across a wide range of industries on enterprise-wide initiatives spanning strategy, growth, cost management, and organizational effectiveness.
He holds a Master of Science in Management from the MIT Sloan School of Management where he serves on the advisory board, and a bachelor’s degree in chemical engineering, with High Honors, from the Illinois Institute of Technology.
“We look forward to the potential of adding Manny to our Board,” said Kevin Lobo, Chair and CEO, Stryker. “His strategic acumen, global leadership experience and track record in transformation will enhance the Board as we grow, evolve and create long-term value for shareholders.”
About Stryker
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.
Contacts
For investor inquiries:
Jason Beach, Vice President, Investor Relations at 269-385-2600 or jason.beach@stryker.com
For media inquiries:
Kim Montagnino, Vice President, Global Communications at 269-385-2600
or kim.montagnino@stryker.com
FAQ
When will Stryker (SYK) shareholders vote on Manny Maceda's board nomination?
What experience does Manny Maceda bring to Stryker's (SYK) board?
What was Manny Maceda's role at Bain before being nominated to Stryker's (SYK) board?
How did Manny Maceda transform Bain during his leadership before the Stryker (SYK) nomination?
